DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers have long struggled to understand how cancer cells hijack one of these ...
CAMBRIDGE, United Kingdom and NEW YORK, October 13, 2025 - Artios Pharma Limited ("Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage ...
Potential first-in-class, and industry-leading DNA polymerase Theta (Polθ) inhibitor, ART6043 demonstrated an attractive tolerability profile, expected PK/PD activity, and promising clinical signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback